Roche to acquire Poseida Therapeutics for $1.5bn
The transaction will close in the first quarter of 2025.
Cytiva Pipe dream to pipeline WP 3
Novartis acquires Kate Therapeutics to advance gene therapies
Genprex links with University of Michigan on lung cancer treatment
Regenxbio eyes 2026 filing for Duchenne muscular dystrophy gene therapy
AstraZeneca picks first Treg cell therapy from Quell Therapeutics partnership
FDA grants accelerated approval for PTC’s AADC deficiency gene therapy
Autolus secures FDA approval for CAR-T cell therapy use in ALL
FDA delays priority review of Neurotech’s eye cell therapy implant
